# SARS-CoV-2 Genomic Surveillance in North Louisiana

> **NIH NIH P20** · LOUISIANA STATE UNIV HSC SHREVEPORT · 2021 · $730,000

## Abstract

ABSTRACT
Viral genomic surveillance is critical for identification of SARS-CoV-2 variants that exhibit biological
characteristics of concern for public health, such as escape from humoral immunity, enhanced
transmissibility, and/or increased pathogenic potential. This competitive revision proposal represents
a collaboration between two LSU Health Shreveport (LSUHS) CoBRE’s (Center for Redox Biology and
Cardiovascular Disease [CRBCD] and Center for Applied Immunology and Pathological Processes
[CAIPP]) and leverages established institutional programs including the Center for Emerging Viral
Threats’ (CEVT) CLIA/CAP certified reference laboratory, ongoing COVID-19 clinical research,
community mass vaccination and testing services, and a highly productive viral genome sequencing
program that have served North and Central Louisiana throughout the pandemic. Additionally, LSUHS
is in active partner with the Louisiana Department of Health (LDH) for these efforts and has a strong
foundation for translation of viral genomic surveillance data into favorable public health outcomes, such
as protection of vulnerable communities and targeted mitigation steps against variants of concern. As
such, this competitive revision supplement will pursue the following two specific aims: Aim 1) Establish
rapid SARS-CoV-2 viral genome sequencing and data sharing prioritized by re-infections and
infections of vaccine recipients; and Aim 2) Perform SARS-CoV-2 viral genome sequencing and
data sharing of moderate to severe COVID-19 patients with predisposing risk factors and/or
cardiopulmonary complications. Together, this work will greatly enhance genomic surveillance of
SARS-CoV-2 in Louisiana, East Texas, and Southern Arkansas to benefit US public health and
advance research regarding this devastating virus.

## Key facts

- **NIH application ID:** 10381353
- **Project number:** 3P20GM121307-04S1
- **Recipient organization:** LOUISIANA STATE UNIV HSC SHREVEPORT
- **Principal Investigator:** Christopher G Kevil
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $730,000
- **Award type:** 3
- **Project period:** 2018-02-01 → 2023-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10381353

## Citation

> US National Institutes of Health, RePORTER application 10381353, SARS-CoV-2 Genomic Surveillance in North Louisiana (3P20GM121307-04S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10381353. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*